Picture of Equillium logo

EQ — Equillium News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Equillium Inc expected to post a loss of 17 cents a share - Earnings Preview

* Equillium Inc  EQ.OQ   EQ.O  is expected to show a fall in
quarterly revenue when it reports  results on March 21
(estimated) for the period ending December 31 2023
    * The La Jolla California-based  company is expected to
report a
59.2% decrease in revenue to $6.425 million from $15.76 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Equillium Inc is for a
loss
of 17 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Equillium
Inc is
$7.00​, above​ its last closing price of $2.64. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.14       -0.17      -0.11     Beat    35.3
 Jun. 30 2023  -0.14       -0.17      -0.10     Beat    40.6
 Mar. 31 2023  -0.25       -0.27      -0.11     Beat    59.6​
 Dec. 31 2022  0.41        -0.03      0.08      Beat    407.7
 ​​Sep.        -0.39       -0.38      -0.40     Missed  -6
 30 2022                                                
 Jun. 30 2022  -0.41       -0.41      -0.41     Met     1.2​
 Mar. 31 2022  -0.37       -0.37      -0.45     Missed  -20.8
 Dec. 31 2021  -0.37       -0.34      -0.36     Missed  -5.3
 This summary was machine generated March 19 at 11:05 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Equillium

See all news